Revolution Medicines, Inc. (NASDAQ:RVMDW) Sees Large Decrease in Short Interest

Revolution Medicines, Inc. (NASDAQ:RVMDW) saw a significant decrease in short interest in the month of September. As of September 15th, there was short interest totaling 703 shares, a decrease of 64.8% from the August 31st total of 2,000 shares. Based on an average daily volume of 25,844 shares, the short-interest ratio is currently 0.0 days.

Revolution Medicines Stock Performance

Revolution Medicines stock traded up $0.65 on Friday, hitting $11.40. 116,314 shares of the stock traded hands, compared to its average volume of 105,124. The business’s fifty day simple moving average is $10.85 and its 200 day simple moving average is $7.23. Revolution Medicines has a 1 year low of $0.23 and a 1 year high of $13.44.

About Revolution Medicines

Revolution Medicines, Inc is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer. The company specializes in medicines designed to inhibit mutated RAS proteins, including KRAS, which are important drivers of many solid tumors and have historically been difficult to target with drugs.

Its research and development pipeline includes RAS(ON) inhibitors intended to block active forms of RAS signaling. Key investigational programs have included pan-RAS inhibitors and mutation-selective candidates directed at alterations such as KRAS G12C and KRAS G12D.